目录号 | 产品详情 | 靶点 | |
---|---|---|---|
T6862 | Apoptosis MAO Monoamine Oxidase | ||
Isatin (2,3-Indolinedione) 是一种单胺氧化酶抑制剂,IC50为3 μM。它也可作为心钠肽刺激和一氧化氮刺激的鸟苷酸环化酶活性的拮抗剂,显示对血清素系统有影响。 | |||
TN2004 | MAO Monoamine Oxidase | ||
Obtusin 是来自决明子种子,是一种高度选择性和竞争性的人单胺氧化酶-A 抑制剂,IC50=11.12 μM,Ki=6.15 μM。它在神经退行性疾病,尤其是焦虑和抑郁中起预防作用。 | |||
T0791 | Others Potassium Channel MRP Monoamine Transporter Autophagy | ||
Reserpine (Serpalan) 是一种从催吐萝芙木的根中发现的生物碱。它抑制去甲肾上腺素吸收到储存囊泡中,导致中枢和外周轴突末端的儿茶酚胺和血清素耗尽。它可作为抗高血压药和抗精神病药以及研究工具。 | |||
T3596 | MAO Monoamine Oxidase | ||
TB5 是一种选择性可逆 hMAO-B 有效抑制剂,Ki=0.11±0.01 μM。 | |||
T7185 | Monoamine Oxidase | ||
(2-Chloropyridin-4-yl)methanamine hydrochloride 是一种选择性的LOXL2抑制剂,IC50=126 nM。 | |||
T5323 | MAO Monoamine Oxidase | ||
Toloxatone (MD 69276) 是可逆的单胺氧化酶 A (MAOA) 抑制剂,是一种抗抑郁剂。 | |||
T3158 | Adrenergic Receptor Monoamine Oxidase Imidazoline Receptor | ||
Harmane (Loturine) 是一种在咖啡和烟草烟雾中发现的 β-咔啉生物碱,是有效的神经毒素,可引起严重的动作震颤和精神病学表现。它还是选择性的单胺氧化酶抑制剂,具有致突变作用,对 MAO A/B 的 IC50值分别为 0.5 和 5 μM。 | |||
T0821 | MAO Monoamine Oxidase | ||
Iproniazid Phosphate 是一种非选择性的,不可逆的单胺氧化酶抑制剂,具有抗抑郁作用。 | |||
T1455 | MAO Transferase Monoamine Oxidase | ||
Nialamide (Nialamid) 是非选择性的,不可逆的单胺氧化酶抑制剂,是一种抗抑郁药。 | |||
T8907 | MAO Monoamine Oxidase | ||
Minaprine dihydrochloride 是一种可逆的单胺氧化酶 MAO-A 抑制剂,对乙酰胆碱酯酶有微弱抑制,是一种抗抑郁类化合物。 |
目录号 | 产品名/同用名 | 种属 | 表达系统 | ||
---|---|---|---|---|---|
TMPJ-00379 | AOC3 Protein, Human, Recombinant (hFc) | Human | Human Cells | ||
Membrane primary amine oxidase(AOC3), also known as vascular adhesion protein (VAP-1) and HPAO, this protein is a member of the semicarbazide-sensitive amine oxidase (SSAO) family. VAP-1 is a type 1 membrane-bound glycoprotein that has a distal adhesion domain and an enzymatically active amine oxidase site outside of the membrane, VAP-1 has adhesive properties, functional monoamine oxidase activity, and possibly plays a role in glucose handling, leukocyte trafficking, and migration during inflammation. This rise in metabolic products contributes to generating advanced glycation end-products and oxidative stress along with the monoamine detoxification in the organism. It is highly expressed on the endothelium of the lung and trachea, and absent from leukocytes and epithelial cells. Membrane-bound VAP-1 releases an active, soluble form of the protein, which may be conducive to increased inflammation and the progression of many vascular disorders. In particular, elevation of VAP-1 activity and the increased enzymatic-mediated deamination is proposed to play a role in renal and vascular disease, oxidative stress, acute and chronic hyperglycemia, and diabetes complications.
|
|||||
TMPY-00506 | GAPDH Protein, Mouse, Recombinant (His) | Mouse | E. coli | ||
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH or G3PDH) is an enzyme of about 37kDa that is consisdered as a cellular enzyme involved in glycolysis. It catelyzes the sixth step of glycolysis. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a pleiotropic enzyme that is overexpressed in apoptosis and in several human chronic pathologies. Its role as a mediator for cell death has also been highlighted. A recent report suggests that GAPDH may be genetically associated with late-onset of Alzheimer's disease. Besides, deprenyl, which has originally been used as a monoamine oxidase inhibitor for Parkinson's disease, binds to GAPDH and displays neuroprotective actions.
|
|||||
TMPY-02446 | GAPDH Protein, Human, Recombinant (His) | Human | E. coli | ||
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH or G3PDH) is an enzyme of about 37kDa that is consisdered as a cellular enzyme involved in glycolysis. It catelyzes the sixth step of glycolysis. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a pleiotropic enzyme that is overexpressed in apoptosis and in several human chronic pathologies. Its role as a mediator for cell death has also been highlighted. A recent report suggests that GAPDH may be genetically associated with late-onset of Alzheimer's disease. Besides, deprenyl, which has originally been used as a monoamine oxidase inhibitor for Parkinson's disease, binds to GAPDH and displays neuroprotective actions.
|
|||||
TMPY-03056 | LSD1 Protein, Human, Recombinant (His & GST) | Human | Baculovirus-Insect Cells | ||
LSD1 belongs to the flavin monoamine oxidase family. It contains 1 SWIRM domain and is a component of an RCOR/GFI/LSD1/HDAC complex. LSD1 interacts directly with GFI1 and GFI1B. LSD1 specifically removes histone H3K4me2 to H3K4me1 or H3K4me0 through a FAD-dependent oxidative reaction. When forming a complex with an androgen receptor (and possibly other nuclear hormone receptors), LSD1 changes its substrates to H3K9me2. Thus LSD1 is considered to act as a coactivator or a corepressor. It may play a role in the repression of neuronal genes. Alone, LSD1 is unable to demethylate H3 'Lys-4' on nucleosomes and requires the presence of RCOR1/CoREST to achieve such activity.
|